Publications by authors named "Manuela Robella"

Claim this Profile
E
Enhanced recovery for cytoreductive surgery and hyperthermic intraperitoneal Chemotherapy: An international survey to assess acceptance and feasibility.
Amaniel Kefleyesus, Naoual Bakrin, Vahan Kepenekian, Chloé Gerbaud-Coulas, Anne Li, Manuela Robella

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Bidirectional Therapy for Peritoneal Metastases: A Systematic Review of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Combined with Systemic Chemotherapy.
Manuela Robella, Marco Vitturini, Andrea Di Giorgio, Matteo Aulicino, Martin Hubner

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of an enhanced recovery after surgery (ERAS) program in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: study protocol for a prospective multicenter interventional trial (EPICH study).
Manuela Robella, Eva Pagano, Lisa Giacometti, Armando Cinquegrana, Luca Pellegrino

Pleura Peritoneum· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Factors for the Discontinuation of Pressurized Intraperitoneal Aerosol Chemotherapy: Enhancing Patient Selection to Improve Oncological Outcomes-A Single-Center Experience.
Matteo Aulicino, Francesco Santullo, Cecilia Orsini, Luca D'Agostino, Martin Hübner, Manuela Robella

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centers.
Manuela Robella, Marco Vaira, Luca Ansaloni, Salvatore Asero, Stefano Bacchetti

Eur J Surg Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of an enhanced recovery after surgery protocol for colorectal cancer in a regional hospital network supported by audit and feedback: a stepped wedge, cluster randomised trial.
Eva Pagano, Luca Pellegrino, Manuela Robella, Anna Castiglione, Francesco Brunetti

BMJ Qual Saf· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella

Ann Surg Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients.
Amaniel Kefleyesus, Aditi Bhatt, Cecilia Escayola, Vladimir Khomyakov, Martin Hübner, Manuela Robella

Front Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robot-assisted esophagectomy with robot-sewn intrathoracic anastomosis (Ivor Lewis): surgical technique and early results.
Alessandra Marano, Sara Salomone, Luca Pellegrino, Paolo Geretto, Manuela Robella

Updates Surg· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella

Eur J Surg Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis.
Andrea Di Giorgio, Antonio Macrì, Federica Ferracci, Manuela Robella, Mario Visaloco

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis.
Manuela Robella, Marco Tonello, Paola Berchialla, Veronica Sciannameo, Alba Maria Ilari Civit

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence.
Enrico Maria Pasqual, Ambrogio P Londero, Manuela Robella, Marco Tonello, Antonio Sommariva

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma.
Shigeki Kusamura, Dario Baratti, Michele De Simone, Enrico Maria Pasqual, Luca Ansaloni, Manuela Robella

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO).
Marco Vaira, Manuela Robella, Marcello Guaglio, Paola Berchialla, Antonio Sommariva

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis.
Fabio Carboni, Mario Valle, Marco Vaira, Paolo Sammartino, Orietta Federici, Manuela Robella

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and safety of PIPAC combined with additional surgical procedures: PLUS study.
Manuela Robella, Martin Hubner, Olivia Sgarbura, Marc Reymond, Vladimir Khomiakov

Eur J Surg Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella

Ann Surg Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella

Ann Surg Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Olivia Sgarbura, Clarisse Eveno, Mohammad Alyami, Naoual Bakrin, Delia Cortes Guiral, Manuela Robella

Pleura Peritoneum· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases.
Manuela Robella, Paola Berchialla, Alice Borsano, Armando Cinquegrana, Alba Ilari Civit

Int J Environ Res Public Health· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis.
Manuela Robella, Michele De Simone, Paola Berchialla, Monica Argenziano, Alice Borsano

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience.
Valentina Tuninetti, Marilena Di Napoli, Eleonora Ghisoni, Furio Maggiorotto, Manuela Robella

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles.
Claudio Isella, Marco Vaira, Manuela Robella, Sara Erika Bellomo, Gabriele Picco

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial.
Michele De Simone, Marco Vaira, Monica Argenziano, Paola Berchialla, Alberto Pisacane, Manuela Robella

Biomedicines· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis